Science Explorer Back to mapMap

Most cited papers from National Tuberculosis Institute

What are the most cited papers from National Tuberculosis Institute?

The most cited paper from National Tuberculosis Institute is "Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013" (Theo Vos et al., 2015), with 6,558 citations. Next come "Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013" (998) and "In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice." (427).

Showing 50 of 60 papers. Every paper with more than 40 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 Theo Vos et al. · The Lancet Open access679 authors 7 Jun 2015 6,558
2 Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 Christopher J L Murray et al. · The Lancet Open access366 authors 21 Jul 2014 998
3 In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. S Habu, H Fukui, Kunihiro Shimamura et al. · The Journal of Immunology Jul 1981 427
4 European framework for tuberculosis control and elimination in countries with a low incidence Jaap F. Broekmans, Giovanni Battista Migliori, H. L. Rieder et al. · European Respiratory Journal Open access Apr 2002 311
5 The Tuberculosis Cascade of Care in India’s Public Sector: A Systematic Review and Meta-analysis Ramnath Subbaraman, Ruvandhi R. Nathavitharana, Srinath Satyanarayana et al. · PLoS Medicine ReviewOpen access 25 Oct 2016 287
6 Community-wide Screening for Tuberculosis in a High-Prevalence Setting Guy Barrington Marks, Nguyen Viet Nhung, Phuong Thi Bich Nguyen et al. · New England Journal of Medicine 2 Oct 2019 235
7 Prevalence of SARS-CoV-2 infection in India ManojV Murhekar et al. · The Indian Journal of Medical Research Open access Jul 2020 225
8 Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models Rein M G J Houben et al. · The Lancet Global Health Open access 10 Oct 2016 212
9 SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey Manoj Vasanth Murhekar et al. · The Lancet Global Health Open access108 authors 27 Jan 2021 210
10 Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open-label, cluster-randomised, controlled trial Anurag Bhargava, Madhavi Bhargava, Ajay Meher et al. · The Lancet Aug 2023 197
11 Surveillance of tuberculosis in Europe. Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting on tuberculosis cases HL Rieder, Judith M. Watson, Mario Carlo Raviglione et al. · European Respiratory Journal Open access May 1996 195
12 Measuring tuberculosis burden, trends, and the impact of control programmes Christopher Dye, Amal Bassili, Ana Luiza Bierrenbach et al. · The Lancet Infectious Diseases 29 Jan 2008 173
13 SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021 Manoj Vasanth Murhekar et al. · International Journal of Infectious Diseases Open access136 authors 19 May 2021 148
14 Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan Sabine Hofmann-Thiel, Jakko van Ingen, Kristine Feldmann et al. · European Respiratory Journal Open access Oct 2008 138
15 Proteogenomic Analysis of Mycobacterium tuberculosis By High Resolution Mass Spectrometry Dhanashree S. Kelkar et al. · Molecular & Cellular Proteomics Open access 3 Oct 2011 131
16 Nutritional support for adult patients with microbiologically confirmed pulmonary tuberculosis: outcomes in a programmatic cohort nested within the RATIONS trial in Jharkhand, India Anurag Bhargava, Madhavi Bhargava, Ajay Meher et al. · The Lancet Global Health Open access 8 Aug 2023 123
17 Risk Factors Associated with Default among New Smear Positive TB Patients Treated Under DOTS in India Sophia Vijay, Prahlad Kumar, Lakbir Singh Chauhan et al. · PLoS ONE Open access 6 Apr 2010 118
18 Exploring the Complex Connection Between Diabetes and Cardiovascular Disease: Analyzing Approaches to Mitigate Cardiovascular Risk in Patients With Diabetes FNU Jyotsna, Areeba Ahmed, Kamal Kumar et al. · Cureus Open access 21 Aug 2023 116
19 Microscopy as a diagnostic tool in pulmonary tuberculosis Ritu Singhal, Vithal Prasad Myneedu · International Journal of Mycobacteriology Open access 2015 116
20 Comparison of Enzyme-Linked Immunospot Assay and Tuberculin Skin Test in Healthy Children Exposed to Mycobacterium tuberculosis Philip C. Hill, Roger H. Brookes, Ifedayo Adetifa et al. · PEDIATRICS May 2006 114
21 Guidelines for conducting tuberculin skin test surveys in high-prevalence countries. Hans L Rieder, Chadha Vk, Nagelkerke Nj et al. · PubMed 2011 114
22 ‘I am on treatment since 5 months but I have not received any money’: coverage, delays and implementation challenges of ‘Direct Benefit Transfer’ for tuberculosis patients – a mixed-methods study from South India Abhay Subhashrao Nirgude, Ajay M. V. Kumar, Collins Timire et al. · Global Health Action Open access 2019 95
23 Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models Nicolas A. Menzies et al. · The Lancet Global Health Open access 10 Oct 2016 95
24 The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment Frederick Adriaan Sirgel, Frederik J. H. Botha, Donald P. Parkin et al. · Journal of Antimicrobial Chemotherapy 1993 91
25 Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: A population-based cross-sectional study Manoj Vasanth Murhekar et al. · PLoS Medicine Open access 10 Dec 2021 88
26 The Profile and Treatment Outcomes of the Older (Aged 60 Years and Above) Tuberculosis Patients in Tamilnadu, South India Ramya Ananthakrishnan, Kaliyaperumal Kumar, M T Ganesh et al. · PLoS ONE Open access 8 Jul 2013 86
27 Effect of Streptomycin on the Incorporation of Amino-Acids labeled with Carbon-14 into Ribonucleic Acid and Protein in a Cell-free System of a Mycobacterium Thomas Erdos, Agnès Ullmann · Nature Feb 1959 85
28 Socio-demographic and AIDS-related factors associated with tuberculosis stigma in southern Thailand: a quantitative, cross-sectional study of stigma among patients with TB and healthy community members Aaron M. Kipp, Petchawan Pungrassami, Kittikorn Nilmanat et al. · BMC Public Health Open access 30 Aug 2011 83
29 Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter, Prospective, Cohort Analysis Pranay Sinha et al. · Clinical Infectious Diseases Open access 23 Nov 2022 82
30 HLA-DR Marks Recently Divided Antigen-Specific Effector CD4 T Cells in Active Tuberculosis Patients Rashmi Tippalagama et al. · The Journal of Immunology Open access 30 Jun 2021 81
31 Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation Muhammad Ali Muzammil, Fnu Fariha, Tirath Patel et al. · Cureus ReviewOpen access 28 Jun 2023 74
32 Short-course Chemotherapy for Tuberculosis with Largely Twice-weekly Isoniazid-Rifampin Asim K. Dutt, Lucile S. Jones, William W. Stead · CHEST Journal Apr 1979 73
33 A Systematic Review of the Effectiveness of Hospital- and Ambulatory-Based Management of Multidrug-Resistant Tuberculosis Amal Bassili, Christopher J. Fitzpatrick, Ejaz Qadeer et al. · American Journal of Tropical Medicine and Hygiene ReviewOpen access 7 Aug 2013 72
34 Relationship between Nutritional Support and Tuberculosis Treatment Outcomes in West Bengal, India Blesson Samue, Tyson A. Volkmann, Sushma Cornelius et al. · Journal of Tuberculosis Research Open access 2016 69
35 Molecular and Conventional Epidemiology of Mycobacterium tuberculosis in Botswana: a Population-Based Prospective Study of 301 Pulmonary Tuberculosis Patients Shahin Lockman, Jeffery D. Sheppard, Christopher R. Braden et al. · Journal of Clinical Microbiology Open access Mar 2001 67
36 Inflammasome activation underlies central nervous system deterioration in HIV-associated tuberculosis Suzaan Marais, Rachel Lai, Katalin Andrea Wilkinson et al. · The Journal of Infectious Diseases Open access 16 Nov 2016 65
37 Tuberculosis epidemiology in India: a review. V K Chadha · PubMed Oct 2005 63
38 Mycobacterium tuberculosis cords within lymphatic endothelial cells to evade host immunity Thomas R. Lerner, Christophe J. Queval, Rachel Lai et al. · JCI Insight Open access 5 May 2020 60
39 Community-based directly observed therapy (DOT) versus clinic DOT for tuberculosis: a systematic review and meta-analysis of comparative effectiveness Cameron M. Wright, Lenna M. Westerkamp, Sarah Körver et al. · BMC Infectious Diseases ReviewOpen access 7 May 2015 59
40 Counting the lives saved by DOTS in India: a model-based approach Sandip Mandal, Vineet Kumar Chadha, Ramanan Laxminarayan et al. · BMC Medicine Open access 20 Feb 2017 58
41 Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study Onno W. Akkerman et al. · International Journal of Infectious Diseases Open access 3 Apr 2019 57
42 TB treatment outcomes among TB-HIV co-infections in Karnataka, India: how do these compare with non-HIV tuberculosis outcomes in the province? Suresh G. Shastri, Balaji Rama Naik, Anita Shet et al. · BMC Public Health Open access 11 Sep 2013 56
43 Prevalence of Pulmonary Tuberculosis - A Baseline Survey In Central India Vikas Gangadhar Rao, Jyothi Bhat, Rajiv Yadav et al. · PLoS ONE Open access 29 Aug 2012 56
44 The Clinical Features and Bacteriological Characterizations of Bone and Joint Tuberculosis in China Su-Ting Chen, Li-Ping Zhao, Wei-Jie Dong et al. · Scientific Reports Open access 8 Jun 2015 55
45 Treatment Outcome and Mortality at One and Half Year Follow-Up of HIV Infected TB Patients Under TB Control Programme in a District of South India Sophia Vijay, Prahlad Kumar, Lakbir Singh Chauhan et al. · PLoS ONE Open access 26 Jul 2011 54
46 Prevalence and factors associated with tuberculosis infection in India Sriram Selvaraju et al. · Journal of Infection and Public Health Open access 12 Oct 2023 53
47 Appropriate DevR (DosR)-Mediated Signaling Determines Transcriptional Response, Hypoxic Viability and Virulence of Mycobacterium tuberculosis Shyamasree De Majumdar, Atul Vashist, Sakshi Dhingra et al. · PLoS ONE Open access 26 Apr 2012 53
48 High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region Viola Dreyer et al. · Genome Medicine Open access 21 Aug 2022 51
49 Average annual risk of tuberculous infection in India. V K Chadha, Pradeep Kumar, P S Jagannatha et al. · PubMed 2005 50
50 Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment – Tamil Nadu, India Karun Sandeep Veesa, Kamalabhai Russell John, Patrick K. Moonan et al. · PLoS ONE Open access 7 Feb 2018 49

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.